The current CYTH market cap is 19.56M. The company's latest EPS is USD -0.6972 and P/E is -0.98.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 495k | 311k | 202k | 124k | 233k |
Operating Income | -4.77M | -5.64M | -5.11M | -5.64M | -8.29M |
Net Income | -4.77M | -5.64M | -4.34M | -5.98M | -8.83M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.01M | 903k | 1.59M | 1.38M | 1.08M |
Operating Income | -7.39M | -8.96M | -14.27M | -15.62M | -20.05M |
Net Income | -7.53M | -8.94M | -14.29M | -15.45M | -20.06M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 5.6M | 13.25M | 7.16M | 4.72M | 5.25M |
Total Liabilities | 6.65M | 8.49M | 6.55M | 9.84M | 18.73M |
Total Equity | -1.05M | 4.76M | 610k | -5.12M | -13.47M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 4.11M | 14.19M | 19.52M | 4.22M | 13.25M |
Total Liabilities | 3.18M | 3.74M | 3.85M | 3.48M | 8.49M |
Total Equity | 936k | 10.45M | 15.67M | 734k | 4.76M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -11.89M | -16.18M | -6.18M | -10.03M | -18.22M |
Investing | N/A | -2k | N/A | N/A | N/A |
Financing | 12.15M | 23.89M | -69k | 1.91M | 9.9M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -6.59M | -8.54M | -15.01M | -15.12M | -16.18M |
Investing | 36k | -14k | 14k | 38k | -2k |
Financing | 7.12M | 18.62M | 18.76M | 7k | 23.89M |
Market Cap | 19.56M |
Price to Earnings Ratio | -0.98 |
Price to Sales Ratio | 18.18 |
Price to Cash Ratio | 2.12 |
Price to Book Ratio | 4.11 |
Dividend Yield | - |
Shares Outstanding | 28.77M |
Average Volume (1 week) | 46.88k |
Average Volume (1 Month) | 50.63k |
52 Week Change | -61.80% |
52 Week High | 2.115 |
52 Week Low | 0.55 |
Spread (Intraday) | 0.05 (6.34%) |
Company Name | Cyclo Therapeutics Inc |
Address |
6714 nw 16th street gainesville, florida 32653 |
Website | https://www.cyclotherapeutics.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.